Health Catalyst, Inc. (HCAT)
| Market Cap | 98.61M |
| Revenue (ttm) | 311.14M |
| Net Income (ttm) | -177.97M |
| Shares Out | 73.59M |
| EPS (ttm) | -2.55 |
| PE Ratio | n/a |
| Forward PE | 10.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 790,025 |
| Open | 1.340 |
| Previous Close | 1.370 |
| Day's Range | 1.295 - 1.370 |
| 52-Week Range | 0.955 - 5.062 |
| Beta | 1.82 |
| Analysts | Hold |
| Price Target | 2.53 (+88.81%) |
| Earnings Date | May 8, 2026 |
About HCAT
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operat... [Read more]
Financial Performance
In 2025, Health Catalyst's revenue was $311.14 million, an increase of 1.48% compared to the previous year's $306.58 million. Losses were -$177.97 million, 156.1% more than in 2024.
Financial StatementsAnalyst Forecast
According to 10 analysts, the average rating for HCAT stock is "Hold." The 12-month stock price target is $2.53, which is an increase of 88.81% from the latest price.
News
Health Catalyst Earnings Call Transcript: Q4 2025
Revenue grew 1% in 2025 to $311.1M, with Adjusted EBITDA up 59% year-over-year. Leadership transition and restructuring actions improved margins, but significant revenue and margin pressure is expected in 2026 due to platform migration and churn risks.
Health Catalyst Reports Fourth Quarter and Year End 2025 Results
SALT LAKE CITY, March 12, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations...
Health Catalyst to Announce Fourth Quarter and Year End 2025 Operating Results and Host Conference Call on Thursday, March 12, 2026
SALT LAKE CITY, March 02, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations...
Health Catalyst Appoints Ben Albert as Chief Executive Officer
Albert to Sharpen Focus on Improving Cost and Operational Efficiency, Clinical Quality, and Consumer Experience in Healthcare Health Catalyst Board to be Reduced to Five Directors Immediately Prior to...
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors
SALT LAKE CITY , Dec. 2, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare o...
Health Catalyst to Participate in Upcoming Investor Conferences
SALT LAKE CITY, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst Earnings Call Transcript: Q3 2025
Q3 2025 results exceeded guidance with $76.3M revenue and $12M adjusted EBITDA. Technology segment grew 7% YoY, while professional services declined due to contract exits. 2026 revenue is expected to dip slightly, but EBITDA should improve as cost controls and restructuring take effect.
UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to...
Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance
SALT LAKE CITY , Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to...
Health Catalyst Reports Third Quarter 2025 Results
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst to Announce Third Quarter 2025 Operating Results and Host Conference Call on Monday, November 10, 2025
SALT LAKE CITY, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst Appoints Ben Albert to the Role of President and COO
Albert Appointed to Drive Health Catalyst Forward in Its Next Chapter of Enabling Measurable Healthcare Improvement SALT LAKE CITY , Sept. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catal...
CyncHealth Nebraska Expands Partnership with Health Catalyst to Accelerate Measurable Improvement in Nebraska
SALT LAKE CITY , Sept. 9, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, to...
Health Catalyst Transcript: Wells Fargo 20th Annual Healthcare Conference 2025
Clients are adjusting to major funding cuts, leading to delayed purchases and tighter budgets. The Egnyte migration is causing near-term retention headwinds, but strong gross margins and cost savings are expected to support EBITDA growth. Capital strategy now focuses on share repurchase and debt reduction.
Health Catalyst Announces Winners of the 2025 Catalyst Awards
Recognizing Healthcare's Data-Driven Innovators at the 2025 Health Catalyst Analytics Summit SALT LAKE CITY , Aug. 29, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a l...
Health Catalyst Announces Upfront: Market Insights on Salesforce AppExchange
Hospitals and Health Systems Can Now Benefit from a Validated Consumer Science Model and Proprietary Business Intelligence SALT LAKE CITY , Aug. 26, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health...
Health Catalyst Earnings Call Transcript: Q2 2025
Q2 2025 revenue and adjusted EBITDA exceeded guidance, but full-year revenue outlook was cut due to major Medicaid and research funding reductions. Profitability focus is driving restructuring, cost cuts, and a shift to higher-margin technology revenue, with adjusted EBITDA guidance reaffirmed.
Health Catalyst Announces CEO Dan Burton to Step Down to Pursue Service Opportunities
Mr. Burton to Retire June 30, 2026, Actively Committed to Support Board in Transition and New CEO Search SALT LAKE CITY , Aug. 7, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq:...
Health Catalyst Reports Second Quarter 2025 Results
SALT LAKE CITY, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025
SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations,...
Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace
SALT LAKE CITY , July 1, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, tod...
Health Catalyst Earnings Call Transcript: Q1 2025
Q1 2025 revenue and adjusted EBITDA exceeded guidance, driven by strong Ignite platform adoption and robust technology segment growth. The company reiterated its full-year targets, expects improved margins in the second half, and remains confident in its cross-sell strategy and pipeline despite macroeconomic uncertainties.
Health Catalyst Reports First Quarter 2025 Results
SALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...
Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations
Health Catalyst's Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers SALT LAKE CITY , April 29, 2025 /PRNewswire/ -...
Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025
SALT LAKE CITY, April 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations...